ESR1 and breast cancer: Compared with estrogen receptor-positive breast cancer cells, LDLR was reportedly expressed at a higher level in a typical TNBC cell line, which in turn, could accelerate the aggressive and metastatic ability of TNBC cells by taking up, storing, and utilizing exogenous LDL-cholesterol mediated by LDLR [45].